vs

Side-by-side financial comparison of CareCloud, Inc. (CCLD) and Talkspace, Inc. (TALK). Click either name above to swap in a different company.

Talkspace, Inc. is the larger business by last-quarter revenue ($63.0M vs $34.4M, roughly 1.8× CareCloud, Inc.). On growth, Talkspace, Inc. posted the faster year-over-year revenue change (29.3% vs 21.9%). Over the past eight quarters, Talkspace, Inc.'s revenue compounded faster (17.8% CAGR vs 15.1%).

CareCloud, Inc. is a publicly traded American healthcare information technology company that provides services, to healthcare providers and hospitals. The Company maintains its headquarters in Somerset, New Jersey, and employs approximately 4,000 workers worldwide.

Talkspace, Inc. is an American company that provides online and mobile therapy services. Founded in 2012 by Oren and Roni Frank, Talkspace connects users with licensed therapists and psychiatrists through web and mobile platforms. The service offers communication through text, audio, and video messaging, as well as live video sessions in some cases. The company is headquartered in New York City.

CCLD vs TALK — Head-to-Head

Bigger by revenue
TALK
TALK
1.8× larger
TALK
$63.0M
$34.4M
CCLD
Growing faster (revenue YoY)
TALK
TALK
+7.4% gap
TALK
29.3%
21.9%
CCLD
Faster 2-yr revenue CAGR
TALK
TALK
Annualised
TALK
17.8%
15.1%
CCLD

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CCLD
CCLD
TALK
TALK
Revenue
$34.4M
$63.0M
Net Profit
$4.8M
Gross Margin
Operating Margin
9.1%
6.1%
Net Margin
7.6%
Revenue YoY
21.9%
29.3%
Net Profit YoY
292.5%
EPS (diluted)
$0.06

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CCLD
CCLD
TALK
TALK
Q4 25
$34.4M
$63.0M
Q3 25
$31.1M
$59.4M
Q2 25
$27.4M
$54.3M
Q1 25
$27.6M
$52.2M
Q4 24
$28.2M
$48.7M
Q3 24
$28.5M
$47.4M
Q2 24
$28.1M
$46.1M
Q1 24
$26.0M
$45.4M
Net Profit
CCLD
CCLD
TALK
TALK
Q4 25
$4.8M
Q3 25
$3.1M
$3.3M
Q2 25
$2.9M
$-541.0K
Q1 25
$1.9M
$318.0K
Q4 24
$1.2M
Q3 24
$3.1M
$1.9M
Q2 24
$1.7M
$-474.0K
Q1 24
$-241.0K
$-1.5M
Gross Margin
CCLD
CCLD
TALK
TALK
Q4 25
Q3 25
Q2 25
Q1 25
44.6%
Q4 24
44.2%
Q3 24
45.6%
Q2 24
45.5%
Q1 24
47.8%
Operating Margin
CCLD
CCLD
TALK
TALK
Q4 25
9.1%
6.1%
Q3 25
10.3%
3.7%
Q2 25
10.9%
-3.3%
Q1 25
7.3%
-2.1%
Q4 24
12.2%
1.2%
Q3 24
11.4%
0.2%
Q2 24
8.1%
-7.6%
Q1 24
0.5%
-3.7%
Net Margin
CCLD
CCLD
TALK
TALK
Q4 25
7.6%
Q3 25
9.8%
5.5%
Q2 25
10.6%
-1.0%
Q1 25
7.0%
0.6%
Q4 24
2.5%
Q3 24
10.9%
4.0%
Q2 24
6.0%
-1.0%
Q1 24
-0.9%
-3.2%
EPS (diluted)
CCLD
CCLD
TALK
TALK
Q4 25
$0.06
Q3 25
$0.04
$0.02
Q2 25
$0.04
Q1 25
$-0.04
$0.00
Q4 24
$0.00
$0.01
Q3 24
$-0.04
$0.01
Q2 24
$-0.14
$0.00
Q1 24
$-0.10
$-0.01

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CCLD
CCLD
TALK
TALK
Cash + ST InvestmentsLiquidity on hand
$37.4M
Total DebtLower is stronger
$1.2M
Stockholders' EquityBook value
$59.5M
$117.0M
Total Assets
$87.6M
$134.9M
Debt / EquityLower = less leverage
0.02×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CCLD
CCLD
TALK
TALK
Q4 25
$37.4M
Q3 25
$39.5M
Q2 25
$54.3M
Q1 25
$60.1M
Q4 24
$76.7M
Q3 24
$119.0M
Q2 24
$114.9M
Q1 24
$120.3M
Total Debt
CCLD
CCLD
TALK
TALK
Q4 25
$1.2M
Q3 25
Q2 25
Q1 25
Q4 24
$336.0K
Q3 24
Q2 24
Q1 24
Stockholders' Equity
CCLD
CCLD
TALK
TALK
Q4 25
$59.5M
$117.0M
Q3 25
$57.8M
$109.1M
Q2 25
$56.1M
$112.9M
Q1 25
$54.2M
$113.4M
Q4 24
$49.8M
$117.4M
Q3 24
$46.5M
$117.6M
Q2 24
$43.2M
$114.0M
Q1 24
$41.4M
$119.6M
Total Assets
CCLD
CCLD
TALK
TALK
Q4 25
$87.6M
$134.9M
Q3 25
$90.6M
$129.1M
Q2 25
$75.2M
$132.8M
Q1 25
$73.6M
$134.2M
Q4 24
$71.6M
$138.7M
Q3 24
$70.7M
$138.2M
Q2 24
$74.0M
$133.8M
Q1 24
$76.9M
$138.3M
Debt / Equity
CCLD
CCLD
TALK
TALK
Q4 25
0.02×
Q3 25
Q2 25
Q1 25
Q4 24
0.01×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CCLD
CCLD
TALK
TALK
Operating Cash FlowLast quarter
$8.7M
$5.4M
Free Cash FlowOCF − Capex
$6.6M
FCF MarginFCF / Revenue
19.0%
Capex IntensityCapex / Revenue
6.2%
Cash ConversionOCF / Net Profit
1.13×
TTM Free Cash FlowTrailing 4 quarters
$23.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CCLD
CCLD
TALK
TALK
Q4 25
$8.7M
$5.4M
Q3 25
$7.4M
$4.7M
Q2 25
$7.4M
$-351.0K
Q1 25
$5.1M
$-1.2M
Q4 24
$5.2M
$3.7M
Q3 24
$7.1M
$6.2M
Q2 24
$4.3M
$4.8M
Q1 24
$4.1M
$-3.4M
Free Cash Flow
CCLD
CCLD
TALK
TALK
Q4 25
$6.6M
Q3 25
$6.5M
Q2 25
$6.2M
Q1 25
$4.5M
Q4 24
$4.3M
Q3 24
$6.7M
Q2 24
$4.2M
$4.5M
Q1 24
$3.8M
$-3.8M
FCF Margin
CCLD
CCLD
TALK
TALK
Q4 25
19.0%
Q3 25
20.9%
Q2 25
22.8%
Q1 25
16.2%
Q4 24
15.2%
Q3 24
23.6%
Q2 24
14.8%
9.7%
Q1 24
14.5%
-8.3%
Capex Intensity
CCLD
CCLD
TALK
TALK
Q4 25
6.2%
Q3 25
2.8%
Q2 25
4.2%
Q1 25
2.3%
Q4 24
3.3%
Q3 24
1.2%
Q2 24
0.5%
0.7%
Q1 24
1.1%
0.8%
Cash Conversion
CCLD
CCLD
TALK
TALK
Q4 25
1.13×
Q3 25
2.41×
1.46×
Q2 25
2.55×
Q1 25
2.62×
-3.90×
Q4 24
3.02×
Q3 24
2.26×
3.31×
Q2 24
2.56×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CCLD
CCLD

Healthcare IT$31.0M90%
Medical Practice Management$3.4M10%

TALK
TALK

Payor Revenue$47.7M76%
Dte Revenue$11.6M18%
Consumer$3.7M6%

Related Comparisons